Handelsbanken Fonder Ab Alector, Inc. Transaction History

Handelsbanken Fonder Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$13.02 - $20.78 $204,414 - $326,246	-15,700 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$19.35 - $25.54 $21,285 - $28,094	-1,100 Reduced 6.55%	15,700 $324,000
Q2 2021 Aug 03, 2021	BUY	$15.5 - $22.48 $260,400 - $377,664	16,800 New	16,800 $350,000
Q3 2020 Nov 13, 2020	SELL	$10.54 - $24.96 $91,697 - $217,152	-8,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$21.87 - $33.11 $190,269 - $288,057	8,700 New	8,700 $213,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.